[HTML][HTML] Melanocortin regulation of inflammation

W Wang, DY Guo, YJ Lin, YX Tao - Frontiers in endocrinology, 2019 - frontiersin.org
W Wang, DY Guo, YJ Lin, YX Tao
Frontiers in endocrinology, 2019frontiersin.org
Adrenocorticotropic hormone (ACTH), and α-, β-, and γ-melanocyte-stimulating hormones (α-
, β-, γ-MSH), collectively known as melanocortins, together with their receptors (melanocortin
receptors), are components of an ancient modulatory system. The clinical use of ACTH in the
treatment of rheumatoid arthritis started in 1949, originally thought that the anti-inflammatory
action was through hypothalamus-pituitary-adrenal axis and glucocorticoid-dependent.
Subsequent decades have witnessed extensive attempts in unraveling the physiology and …
Adrenocorticotropic hormone (ACTH), and α-, β-, and γ-melanocyte-stimulating hormones (α-, β-, γ-MSH), collectively known as melanocortins, together with their receptors (melanocortin receptors), are components of an ancient modulatory system. The clinical use of ACTH in the treatment of rheumatoid arthritis started in 1949, originally thought that the anti-inflammatory action was through hypothalamus-pituitary-adrenal axis and glucocorticoid-dependent. Subsequent decades have witnessed extensive attempts in unraveling the physiology and pharmacology of the melanocortin system. It is now known that ACTH, together with α-, β-, and γ-MSHs, also possess glucocorticoid-independent anti-inflammatory and immunomodulatory effects by activating the melanocortin receptors expressed in the brain or peripheral immune cells. This review will briefly introduce the melanocortin system and highlight the action of melanocortins in the regulation of immune functions from in vitro, in vivo, preclinical, and clinical studies. The potential therapeutic use of melanocortins are also summarized.
Frontiers